Advertisement
ResearchIn-Press PreviewImmunologyInflammation
Open Access |
10.1172/JCI206638
1Section of Rheumatology, The University of Chicago, Chicago, United States of America
2Section of Transplantation, The University of Chicago, Chicago, United States of America
Find articles by
Cassano, A.
in:
PubMed
|
Google Scholar
|
1Section of Rheumatology, The University of Chicago, Chicago, United States of America
2Section of Transplantation, The University of Chicago, Chicago, United States of America
Find articles by
Abbondanza, D.
in:
PubMed
|
Google Scholar
|
1Section of Rheumatology, The University of Chicago, Chicago, United States of America
2Section of Transplantation, The University of Chicago, Chicago, United States of America
Find articles by Wang, Y. in: PubMed | Google Scholar
1Section of Rheumatology, The University of Chicago, Chicago, United States of America
2Section of Transplantation, The University of Chicago, Chicago, United States of America
Find articles by Wu, S. in: PubMed | Google Scholar
1Section of Rheumatology, The University of Chicago, Chicago, United States of America
2Section of Transplantation, The University of Chicago, Chicago, United States of America
Find articles by McIntosh, C. in: PubMed | Google Scholar
1Section of Rheumatology, The University of Chicago, Chicago, United States of America
2Section of Transplantation, The University of Chicago, Chicago, United States of America
Find articles by
Wang, P.
in:
PubMed
|
Google Scholar
|
1Section of Rheumatology, The University of Chicago, Chicago, United States of America
2Section of Transplantation, The University of Chicago, Chicago, United States of America
Find articles by Allocco, J. in: PubMed | Google Scholar
1Section of Rheumatology, The University of Chicago, Chicago, United States of America
2Section of Transplantation, The University of Chicago, Chicago, United States of America
Find articles by Kwan, M. in: PubMed | Google Scholar
1Section of Rheumatology, The University of Chicago, Chicago, United States of America
2Section of Transplantation, The University of Chicago, Chicago, United States of America
Find articles by Mora-Cartin, R. in: PubMed | Google Scholar
1Section of Rheumatology, The University of Chicago, Chicago, United States of America
2Section of Transplantation, The University of Chicago, Chicago, United States of America
Find articles by Craddock, E. in: PubMed | Google Scholar
1Section of Rheumatology, The University of Chicago, Chicago, United States of America
2Section of Transplantation, The University of Chicago, Chicago, United States of America
Find articles by
Andrade, M.
in:
PubMed
|
Google Scholar
|
1Section of Rheumatology, The University of Chicago, Chicago, United States of America
2Section of Transplantation, The University of Chicago, Chicago, United States of America
Find articles by
Chong, A.
in:
PubMed
|
Google Scholar
|
1Section of Rheumatology, The University of Chicago, Chicago, United States of America
2Section of Transplantation, The University of Chicago, Chicago, United States of America
Find articles by Alegre, M. in: PubMed | Google Scholar
Published November 19, 2026 - More info
Donor-specific transplantation tolerance promises to free recipients from complications associated with lifelong immunosuppression. Anergy, a CD4+ conventional T cell (Tconv)-intrinsic state of long-term hypofunction, is thought to arise when T cells encounter cognate antigen in the absence of costimulation. Anti-CD154 (αCD154), an antibody that blocks T cell costimulation and is currently in clinical trials, can induce donor-specific transplantation tolerance in mice in association with anergy of Tconvs recognizing persistently expressed alloantigens. Using murine models of fully mismatched cardiac allograft tolerance or repeated alloantigen exposure, we demonstrate that αCD154 is not sufficient and regulatory T cells (Tregs) are necessary to induce and sustain αCD154-mediated alloreactive Tconv anergy. Transient depletion of Tregs disrupted the induction of αCD154-mediated Tconv anergy, and in mice with established tolerance, Treg depletion transcriptionally and functionally reinvigorated previously anergic Tconvs. Mechanistically, Treg depletion increased IL-2 availability and IL-2R signaling in Tconvs, and exogenous IL-2 could bypass Treg-mediated control to partially restore Tconv function. Thus, the state of αCD154-mediated Tconv anergy is less cell-intrinsic than previously thought and requires Tregs to limit IL-2 availability for both its induction and its continuous enforcement. Selecting immunosuppressive drugs that preserve this Treg function may be critical for achieving stable clinical transplantation tolerance.
View Figure 3G publication license
View Sup Fig 7B publication license
View Fig 1E publication license
View Sup Fig 8D publication license
View Sup Fig 1A publication license
View Fig 6B publication license
View Fig 6G publication license
View Fig 1A publication license
View Fig 1G publication license
View Fig 2A publication license
View Fig 3A publication license
View Fig 6D publication license
View Fig 3E publication license
View Fig 5A publication license
View Sup Fig 5A publication license
View Fig 4A publication license
View Sup Fig 4D publication license
View Sup Fig 2E publication license
View Sup Fig 8A publication license